B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ALDH2

MOLECULAR TARGET

aldehyde dehydrogenase 2 family member

UniProt: P05091NCBI Gene: 2178 compounds

ALDH2 (aldehyde dehydrogenase 2 family member) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ALDH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1magnolol3.7843
24 hydroxychalcone3.0921
3daidzin2.8917
4thiram2.4811
5bispiperidinylthiocarbonyldisulfide2.208
6Pueraria1.102
7Disulfiram1.102
8prunetin0.691

About ALDH2 as a Drug Target

ALDH2 (aldehyde dehydrogenase 2 family member) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented ALDH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ALDH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.